Skip to main content
Premium Trial:

Request an Annual Quote

Modern Mobility Aids Buying POC MDx Firm Lumigene Technologies

NEW YORK (GenomeWeb News) – Modern Mobility Aids today announced the execution of a definitive agreement to buy all of the common stock of point-of-care diagnostics shop Lumigene Technologies for an undisclosed amount.

Based in Mississauga, Ontario, LumiGene develops products for the diagnosis of infectious diseases. In a statement, Modern Mobility said that LumiGen's PosiCheck System, which is based on isothermal amplification technology, for the near sample/point-of-care DNA diagnostic markets "reliably and economically" automates DNA preparation and amplification for disease and pathogen detection in 30 minutes to one hour.

"LumiGene expects to be the first to market with a greatly needed new technology that we expect will be in high demand," Mohamed Karatella, president and CEO of Modern Mobility, said in a statement.

In September, LumiGene announced a reverse acquisition to be purchased by dance studio Pole Perfect Studios in a deal that would have taken LumiGene public. The deal was never completed, however.

Modern Mobility is based in Schaumburg, Ill., and recently underwent a corporate restructuring to focus on the pharmaceutical and biotechnology space.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.